Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Cortellis
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Cortellis
-
MENA regulators are looking to implement HTA to more efficiently evaluate healthcare interventions. Gain insights into the current state of HTA in MENA. Read the article: https://bit.ly/39NmNsa
#regulatoryaffairs#Pharmaceutical#MENA#HTApic.twitter.com/sRKQmUJOto
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Access existing
#coronavirus research to better guide your efforts with free access to@Cortellis Drug Discovery Intelligence, which includes drug pipelines, disease briefings, experimental pharmacology, pharmacokinetics, targets & more: http://bit.ly/36PoTVH#nCoV#2019nCoVHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The buzz around the microbiome & its effects on human health has generated significant growth in research. But how can we harness insights from the vast amounts of data generated? Read the article to find out: https://bit.ly/2PZwo5O
#microbiome#microbiomeresearchpic.twitter.com/MRZ2d022vQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cortellis proslijedio/la je Tweet
Clarivate's new
#coronavirus resource center offers leading research from#WebofScience, breaking news from#Bioworld and complimentary access to#Cortellis Drug Discovery Intelligence for the latest on the evolving health crisis: https://bit.ly/36PoTVH#nCoV#2019nCoVHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#RAC20 comes to close. Great presentations and hot topics discussed (Authorities future strategy, telematic projects, worksharing relevance or role of big data). Looking forward to 20th RAC!pic.twitter.com/Phx7tGRPFx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Iteresting session at
#RAC20 on How to handle digital compound? To highlight vision presented “EMA is interested and open to innovation and engagement early and throughout clinical trial endoint development”Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New drug monograph on Zoliflodacin for the treatment of uncomplicated gonorrhea just published in Drugs of the Future. Check out the latest issue at http://bit.ly/30DsZyu
#drugsofthefuture#biotech#pharma#drugdevelopment#infections#zoliflodacin#Entasis#gonorrheapic.twitter.com/ntviv2moyS
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PharmaMar receives $200 million upfront payment from Jazz after expiration of Hart-Scott-Rodino waiting period for lurbinectedin license agreement signed in December 2019
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Geat 1ºsession at
#RAC20 where it has been highlighted that collaboration between regulators & industry is needed to get more integrated approach for multiple jurisdictions (as a reference product for several jurisdictions), this should be a principal to respond to globalization.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
#PHV20 comes to close. Exellent and lively discussions have been held between regulators and industry representatives regarding current hot topics as the role of big data in patient safety, worksharing importance to get harmonization of requirements or latest inspection trends.pic.twitter.com/7OkRyGlwIB
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
As regards communication of safety information: How can end user experience (physicians and patients) be improved? This was a common topic in some sessions of the
#PHV20Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm, new monograph available in Drugs of Today. Check out the latest issue at http://bit.ly/2RA5cLU
#drugsoftoday#biotech#pharma#drugdevelopment#tagraxofusp#Stemline#Elzonris#BPDCNpic.twitter.com/BKLwJiWRbb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interesting session at
#PHV20 on highlights and overview on what it has been learned from EudraVigilance pilotHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Get up to speed on the latest regulatory developments. Discover the key trends and changes that pharma companies should anticipate for a successful 2020. Register for the January 29th webinar: https://bit.ly/2FcOdJA
#pharma#regulatory#compliance#biotech#FDA#HTA#EMApic.twitter.com/FoGU7aBwQa
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Regenerative Medicine of Latin America to sell Zhittya Genesis Medicine's biological drugs in Latin American market
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Delivering extended value across the entire drug, device and
#medtech innovation lifecycle. That’s the impact of@Clarivate’s pending#lifesciences acquisition: https://bit.ly/36XoYaB#DRGtoJoinClarivate#pharma#healthcare#biotechHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Attending the 19th Regulatory and Scientific Affairs Conference
#RAC20 We'll report on the regulators, industry experts and hear about the new EU political landscape - how will it impact the pharmaceutical regulatory environment? https://bit.ly/2RAXktE@medicinesforEUpic.twitter.com/WUW4lHUELH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Looking forward to reporting from
#PVH20 in Amsterdam. How will you#Engage#Discover#Prepare#Simplify#Improve#Impact Hear from regulators and leading experts talk about challenges and opportunities in Pharmacovigilance for 2020 https://bit.ly/2ttI3Tt@medicinesforEUpic.twitter.com/WiZRWRTCpy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.